. "Appendix T: Additional Sources of Advice to the Committee." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development Establishing Priorities, Volume I: Diseases of Importance in the United States
Walter R.Dowdle, The Centers for Disease Control, Atlanta, Ga.
Gordon R.Dreesman, Baylor College of Medicine, Houston, Tex.
David J.Drutz, University of Texas Health Sciences Center, San Antonio.
Robert Edelman, National Institutes of Health, Bethesda, Md.
Paul Eggers, Health Care Financing Administration, Baltimore, Md.
Roger W.Evans, Battelle Human Affairs Research Centers, Seattle, Wash.
Stanley Falkow, Stanford University, Calif.
Patricia Ferrieri, University of Minnesota, Minneapolis.
Samuel B.Formal, Walter Reed Army Medical Center, Wash., D.C.
Hjordis M.Foy, University of Washington, Seattle.
Donald P.Francis, The Centers for Disease Control, Atlanta, Ga.
Carl E.Frasch, Food and Drug Administration, Bethesda, Md.
Vincent A.Fulginiti, University of Arizona College of Medicine, Tuscon.
Robert J.Gerety, Food and Drug Administration, Bethesda, Md.
Anne A.Gershon, New York University Medical School, N.Y.
Janet R.Gilsdorf, C.S.Mott Children’s Hospital, Ann Arbor, Mich.
W.Paul Glezen, Baylor College of Medicine, Houston, Tex.